Catia is a Managing Director at L.E.K. Consulting’s Life Sciences practice in San Francisco, specializing in precision medicine, diagnostics, and advanced research tools. Since joining in 2017, she has advised on growth strategy, commercial planning, and business development, with a focus on helping biopharma, diagnostics, and research tools clients navigate complex markets and innovate strategies. Her project work includes designing diagnostic strategies for Alzheimer's disease, developing precision medicine approaches in immunology, and crafting commercial strategies for new diagnostic platforms.
Prior to joining L.E.K., Catia was a Postdoctoral Fellow at the Wyss Institute at Harvard University, where her research focused on developing novel immunotherapies. She holds a Ph.D. in Bioengineering from Harvard University and a B.S. in Biology from the Massachusetts Institute of Technology.
Education
Undergraduate: Bachelor of Science in Biology, Massachusetts Institute of Technology
Graduate: Ph.D. in Bioengineering, Harvard University
